TickerFacts.

Nutra Pharma Corp (NPHC): R&D Expense

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest R&D Expense is for the year ended 2012-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$3.0K
Year ended 2012-12-31
$191.8K2010-12-31: $191.8K2011-12-31: $90.9K2012-12-31: $3.0K$3.0K
2010-12-31 R&D Expense (USD) 2012-12-31
Period endedR&D ExpenseChange YoYSource filing
2012-12-31$3.0K-96.6%2013-04-16, From 2012-01-01
2011-12-31$90.9K-52.6%2013-04-16, From 2011-01-01
2010-12-31$191.8Kn/a2012-11-15, From 2010-01-01